Megazone and Hanmi Science Join Forces on Pharmaceutical, Healthcare AX Collaboration... Hanmi Group Pushes Work Innovation
IT DAILY ·
✦ AI Summary
Megazone signed an AX-based digital work innovation memorandum of understanding with Hanmi Science at Hanmi Group headquarters in Songpa-gu, Seoul, on the 26th.
The two companies will combine Megazone's AI and cloud capabilities with Hanmi Science's pharmaceutical and healthcare expertise to identify AI services with on-site usability and commercial viability.
After the agreement is signed, they plan to form a working consultative body to identify specific cooperation tasks, review implementation measures, and gradually expand the scope of cooperation.
Megazone will pursue AX-based work innovation in the pharmaceutical and healthcare sectors with Hanmi Science. Megazone is the parent company of MegazoneCloud, and this collaboration aims to connect AX in the pharmaceutical and healthcare sectors to actual workplace innovation by combining Megazone's AI and cloud capabilities with Hanmi Science's industry expertise.
Megazone announced on the 31st that it signed a memorandum of understanding with Hanmi Science on AX-based digital work innovation at Hanmi Group headquarters in Songpa-gu, Seoul, on the 26th. The signing ceremony was attended by MegazoneCloud Chairman Lee Joo-wan, Megazone CEO Jang Ji-hwang, Hanmi Science CEO Kim Jae-gyo, President Lim Jong-hoon, and key officials.
The two companies agreed to combine Megazone's AI and cloud technology capabilities with Hanmi Science's pharmaceutical and healthcare industry expertise. Based on this, they plan to identify AI services with on-site usability and commercial viability.
Through the memorandum of understanding, the two companies plan to roll out the AI services they identify across Hanmi Group. They also agreed to work together to strengthen digital innovation capabilities across Hanmi Group.
The agreement provides a framework for the two companies to jointly identify AX-based work innovation tasks and cooperate to strengthen digital transformation capabilities. They also plan to pursue other AI and digital innovation-related tasks together.
Under a policy that reflects the characteristics of work in the pharmaceutical and healthcare sectors, the two companies aim to solve real-world problems that are difficult to address with general-purpose AI technology. To this end, they plan to jointly design practical AI services with usability and commercial viability.
After the agreement is signed, they plan to form a working consultative body. Through this, they will identify specific cooperation tasks, review implementation measures, and gradually expand the scope of cooperation while deepening the partnership.
Hanmi Science has recently been running the "Hanmi AI Boost Program" for all affiliates, including Hanmi Pharm. Through this program, Hanmi Science is seeking to spread a culture of AI use and identify cases of work innovation, while also actively laying the groundwork for AX.
Megazone CEO Jang Ji-hwang said that combining deep understanding of technology, industry, and work is necessary to create results in AI business. He added that the company aims to pursue a business model capable of creating new value by combining Hanmi Science's pharmaceutical and healthcare expertise with Megazone's cloud and AI-based work innovation experience and capabilities.
Hanmi Science CEO Kim Jae-gyo said AI is not just a tool for improving work efficiency, but a core technology that determines corporate competitiveness. He also said the company will use this agreement as an opportunity to expand AX-based work innovation across Hanmi Group and promote the building of a digital work environment to improve employees' work efficiency.
Source: IT DAILY · Yang Seung-gap
Original: https://www.itdaily.kr/news/articleView.html?idxno=241312
References
This article was produced with the help of an automated content generation algorithm.
Source: IT DAILY
View originalThis article was summarized and organized by BizCrush based on the original article from IT DAILY. For exact quotations and full details, please refer to the original article.